New dementia drugs: patients to pay privately or face NHS postcode lottery

New dementia drugs: patients to pay privately or face NHS postcode lottery Groundbreaking new dementia drugs are likely to be the preserve of the rich while NHS patients will be subject to a “massive postcode lottery” when they become available for the first time in the UK, according to the co-chair of the government’s national mission to tackle the condition.

Amid multiple scientific and pharmaceutical breakthroughs – the latest of which, donanemab, is to have its full clinical trial results published at a conference in the Netherlands on Monday – more research funding and the establishment of a dedicated government taskforce, it should be a promising time for tackling the disease that affects more than 850,000 people in Britain. The Guardian

See also:

• New drug claims to slow mental decline caused by Alzheimer's The Daily Mail